Live feed
Filing
SC 13D/A
SC 13D/A0000914121-19-001251·EAGLE PHARMACEUTICALS, INC.
Schedule 13D ownership disclosure
EAGLE PHARMACEUTICALS INC
Security class unavailable · CUSIP: 269796108
Event date: 2019-05-10
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914121-19-001251
- Form type
- SC 13D/A
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- May 14, 2019
- Reporting period
- May 10, 2019
- Description
- Schedule 13D beneficial ownership